Markus Puhlmann - Dec 12, 2023 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)

Role
Chief Medical Officer
Signature
/s/ Markus Puhlmann
Stock symbol
CATX
Transactions as of
Dec 12, 2023
Transactions value $
$0
Form type
4
Date filed
12/14/2023, 06:44 PM
Previous filing
Feb 13, 2023
Next filing
Dec 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CATX Stock Options (right to buy) Award $0 +1.48M +104.94% $0.00 2.89M Dec 12, 2023 Common Stock 1.48M $0.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% vested as of 12/12/2023, and the remaining 75% will vest over the next three (3) years, commencing on 12/12/2024, until fully vested.